查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1134517

东莨菪碱的全球市场:现状分析与预测(2022年～2028年)

Scopolamine Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 154 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球东莨菪碱的市场规模，2020年将达到4亿美元以上，在预测期间(2022年～2028年)时预计将以约5％的年复合成长率。世界范围内越来越多的旅行者、越来越多的晕车患者以及更多因慢性病而进行的手术正在推动东莨菪碱市场的增长。

本报告提供全球东莨菪碱市场的相关调查，提供市场洞察，市场趋势，竞争模式，企业概要等全面性资讯。

目录

第1章 市场简介

  • 市场定义
  • 主要目的
  • 相关利益者
  • 限制

第2章 调查方法或假设

  • 东莨菪碱市场调查流程
  • 东莨菪碱市场调查手法
  • 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 东莨菪碱市场的COVID-19影响

第6章 东莨菪碱市场收益(2020年～2028年)

第7章 市场洞察:各剂型

  • 注射剂
  • 锭剂
  • 经皮吸收贴片
  • 其他

第8章 市场洞察:各流通管道

  • 医院药局
  • 零售药局
  • 其他

第9章 市场洞察:各地区

  • 北美
    • 美国
    • 加拿大
    • 其他的北美
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他的亚太地区
  • 全球其他地区

第10章 东莨菪碱市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第11章 东莨菪碱市场机会

第12章 东莨菪碱市场趋势

第13章 需求面和供给面的分析

  • 需求面分析
  • 供给面分析

第14章 价值链分析

第15章 竞争模式

  • 竞争情形
    • 波特的五力分析

第16章 公司概要

  • Pfizer Inc.
  • Baxter International Inc.
  • Myungmoon Pharm Co Ltd
  • Novartis AG
  • Perrigo Company PLC
  • Fine Chemicals Corporation
  • GSK plc
  • Alchem International Pvt. Ltd.
  • Phytex Australia Pty Ltd
  • Caleb Pharmaceuticals, Inc.

第17章 免责声明

简介目录
Product Code: UMHE211161

Global Scopolamine Market was valued at more than USD 400 million in 2020 and is expected to grow at a significant rate of around 5% during the forecast period. The global scopolamine market is anticipated to witness an uptick owing to the rising number of people having motion sickness, and growing awareness among the population globally. About 1 in 3 people are considered highly susceptible to motion sickness. Furthermore, American Institute of Stress, 80% of U.S. workers said that they experience stress on the job. Also, Over three-quarters of adult report symptoms of stress, including headache, tiredness, or sleeping problems, as per the American Psychological Association, 2019. This rising number of people having psychological stress is also one of the prominent factors due to which people feel motion sickness which in turn is also increasing the demand for scopolamine drugs among the population. In addition to this, the growing number of travelers across the globe and an increasing number of surgeries due to chronic diseases are also some of the factors contributing to the growth of the market.

Pfizer Inc., Baxter International Inc., Myungmoon Pharm Co Ltd., Novartis AG, Perrigo Company PLC, Fine Chemicals Corporation, GSK plc, Alchem International Pvt. Ltd., Phytex Australia Pty Ltd., Caleb Pharmaceuticals, Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with scopolamine.

 

Insights Presented in the Report:

"Amongst dosage form, transdermal patches category to witness higher CAGR during the forecast period"

Based on dosage form, the scopolamine market is segmented into injectables, tablets, transdermal patches, and others. The transdermal patches scopolamine segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe as they are widely for the treatment of motion sickness nowadays. Furthermore, growth in the number of domestic and international travelers and in areas of product launches in the market is also positively influencing the growth of the market.

"Amongst distribution channel, the hospital pharmacies to hold a significant share in the market in 2020"

On the basis of distribution channels, the market is fragmented into hospital pharmacies, retail pharmacies, and others. Among these, the hospital pharmacies to hold a significant share in the market in 2020. This is mainly due to the increasing preference of the patients to avail treatment in hospitals and the easy availability of the medication in hospital pharmacies. However, the online pharmacy segment is expected to witness significant growth owing to the growing penetration of e-pharmacy platforms across the world coupled with increasing awareness regarding services offered by e-pharmacy.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the All-Terrain Vehicle industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, a rising number of surgeries, and an increasing number of travelers in the region. For instance, U.S. domestic travel increased 1.7% in 2019 to a total of 2.3 billion person-trips. Also, Leisure travel accounted for 80% of all U.S. domestic travel in 2019. Furthermore, the presence of key industry players in the region and an increasing number of product launches are also some of the factors contributing to the market growth.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global scopolamine market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Scopolamine Market
  • 2.2. Research Methodology of the Scopolamine Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE SCOPOLAMINE MARKET

6 SCOPOLAMINE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY DOSAGE FORM

  • 7.1. Injectables
  • 7.2. Tablets
  • 7.3. Transdermal Patches
  • 7.4. Others

8 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

  • 8.1. Hospital Pharmacies
  • 8.2. Retail Pharmacies
  • 8.3. Others

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 SCOPOLAMINE MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 SCOPOLAMINE MARKET OPPORTUNITIES

12 SCOPOLAMINE MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Pfizer Inc.
  • 16.2. Baxter International Inc.
  • 16.3. Myungmoon Pharm Co Ltd
  • 16.4. Novartis AG
  • 16.5. Perrigo Company PLC
  • 16.6. Fine Chemicals Corporation
  • 16.7. GSK plc
  • 16.8. Alchem International Pvt. Ltd.
  • 16.9. Phytex Australia Pty Ltd
  • 16.10. Caleb Pharmaceuticals, Inc.

17 DISCLAIMER